Pediatric Dermatology

Latest News



Washington - Clobetasol delivered in a foam vehicle is associated with significant improvement of hand dermatitis and appears to be preferred by patients over other vehicles, leading to a high rate of compliance, said J. Mark Jackson, M.D., assistant clinical professor of medicine and dermatology, division of dermatology, University of Louisville.

Musicians risk such afflictions as "guitar nipple" or "fiddler's neck" because of playing their instruments, a new dermatology study has reported.

Ear cartilage is more prone to a nasty infection than the earlobe during jewelry piercing. The infection can cause disfiguring

The Food and Drug Administration said consumers should stay away from Green Hornet, a liquid pitched as an herbal form of the illegal drug ecstasy. The agency has received reports of four teens taking Green Hornet and being hospitalized for seizures, excessive heart rates, severe body rashes, and high blood pressure. The FDA said the herbal liquid, sold on the Internet and in stores, is illegal because it contains active drugs not listed on the label and because Green Hornet claims to be an alternative to a street drug.

Washington - Results from two multicenter, randomized, double-blind trials demonstrate that tacrolimus ointment 0.03 percent (Protopic) is a safe and effective treatment for mild to moderate atopic dermatitis in pediatric patients and adults.

In a continuing series from Dermatology Times , a panel of pediatric masters discusses treatment options for specific and unusual cases. This second case is that of a 13-year-old girl who presents a progressive area of alopecia over the frontal parietal scalp. There is an ivory scleratic plaque with an extension to the forehead. What do you do?

Source: www.biotechnologyhealthcare.com Austin, Texas ? Introgen Therapies announced initiation of a Phase II clinical trial of INGN 241 in patients with metastatic melanoma.

Source: www.PRNewswire.com Connetics Corp., a specialty pharmaceutical company focused on dermatology announced Thursday, April 8 that it has received confirmation that the FDA has accepted for filing the company's NDA for Extina, as of Jan. 26, 2004, with a user fee goal date of Sept. 24, 2004.

Liability reform

American Medical Association President Donald J. Palmisano, M.D., J.D., issued the following statement supporting S. 2061.

Oregon Health & Science University School of Medicine researchers hope treating babies newly diagnosed with eczema using the study drug Elidel will not only control painful skin flare-ups, but also ultimately prevent the onset of childhood asthma.

Physicians may not need to prescribe antibiotics when treating a common skin infection in children, according to researchers at UT Southwestern Medical Center in Dallas.

Connetics Corp. has agreed to acquire exclusive U.S. rights to Roche Holding AG's Soriatane (acitretin).

Acne drug problems

U.S. officials are considering again whether to tighten restrictions on the use of a prescription drug that is highly effective against severe acne but can cause birth defects.